United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.61, $0.07 better than the analyst estimate of $3.54. Revenue for the quarter came in at $370.5 million versus the consensus estimate of $398.18 million.

For earnings history and earnings-related data on United Therapeutics (UTHR) click here.